Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Nanoencapsulated Sirolimus Plus Pegadricase (NASP) in Uncontrolled Gout: Current Status and Future Directions.Drugs · 2026
   Review
2. Optimization and characterization of miRNA-129-5p-encapsulated poly (lactic-Nanoscale advances · 2023
   Article
3. Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease.Nature reviews. Gastroenterology & hepatology · 2021
   Article
4. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models.Science translational medicine · 2021
   Article
5. Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases.Frontiers in immunology · 2021
   Review
6. Base editing: advances and therapeutic opportunities.Nature reviews. Drug discovery · 2020
   Review
7. Nano-bio interactions: a neutrophil-centric view.Cell death & disease · 2019
   Review
8. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.ACS nano · 2019
   Article
9. Polymeric micro- and nanoparticles for immune modulation.Biomaterials science · 2018
   Review
10. A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.Drug discovery today · 2018
    Review
11. Direct modulation of myelin-autoreactive CD4International journal of nanomedicine · 2018
    Article

Corrections and comments

• Erratum for
  Harnessing nanoparticles for immune modulation.2015

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.